↓ Skip to main content

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
4 X users
patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
13 Mendeley